LifeSpark Pharma — Oncology · Pulmonology · Cardiology · Diabetology · Orthopaedic · Neurology · Nutraceutical · OTC — Partner With Us
LIFESPARK Pharma Private Limited

Oncology

Targeted therapies and supportive care for oncology management.

Shielding Lives with Science

Our Oncology Division is a dedicated pillar of our superspeciality ethical portfolio, focused on expanding access to high-quality oncology therapies across India. Headquartered in Mumbai, this division focuses on the development and distribution of oncology medicines across a range of therapeutic areas.

Read the full profile

We bridge the gap between complex molecular science and patient affordability. Our portfolio includes advanced cytotoxic formulations, targeted oral therapies, monoclonal antibodies, and critical supportive care medications for the management of various malignancies and improving the patient's overall quality of life. We combine scientific expertise, quality-focused partnerships and reliable supply capabilities to help make essential oncology treatments more accessible to healthcare professionals and patients.

Who we serve

3 groups this division works for

  1. 01 Oncologists & Medical Professionals

    We provide support to oncology professionals with access to established and emerging therapeutic options, accompanied by scientifically grounded medical information and product support.

  2. 02 Hospitals & Cancer Research Centres

    We serve corporate hospitals, trust hospitals, cancer centres and specialised oncology daycare facilities requiring consistent, temperature-controlled institutional supplies with reliable access to oncology medicines and institutional supply solutions.

  3. 03 Cancer Patients & Caregivers

    We offer affordable, international-quality therapeutic options to ease the financial burden of long-term cancer care.

Medical & Scientific Affairs

Our Medical & Scientific Affairs team supports evidence-based scientific exchange with healthcare professionals. We provide scientifically accurate information on our oncology portfolio, including product characteristics, clinical evidence, safety information and appropriate use in accordance with approved prescribing information.

How to engage

Ways to partner with us

We welcome strategic collaborations to expand the reach of our oncology portfolio across pan-India markets. You can partner with us through multiple engagement models:

Institutional & Hospital Supply Partnerships

The opportunity
Partner with us for bulk institutional procurement, rate contracts, and hospital formulary listings.
Our support
Our dedicated corporate team handles documentation, regulatory and compliance certificates, and efficient supply logistics directly from our Mumbai hub.

Third-Party Manufacturing & Contract Development

The opportunity
Leverage our strategic ties with state-of-the-art, WHO-GMP certified manufacturing facilities to develop your own oncology formulations.
Our support
We offer end-to-end support from formulation development to regulatory filings and commercial manufacturing through qualified manufacturing partners.
Send an enquiryReach the Oncology desk directly Partner with usDistribution and institutional supply Report a side effectPharmacovigilance and complaints Science & QualityHow every product is made and released
Product range

17 products in this division

See all products
Palbocilif 75 mg Palbocilif 100 mg Palbocilif 125 mg Lifgemci 1.4 g Lifgemci 200 mg Lifoxali 50 mg Lifoxali 100 mg Lifdoce (Aqualip) 20 mg Lifdoce (Aqualip) 80 mg Lifdoce (Aqualip) 120 mg Irinolif 40 mg Irinolif 100 mg
Other divisions

Explore the rest of LifeSpark

All divisions
Pulmonology Cardiology Diabetology Orthopaedic Neurology Nutraceutical OTC

Enquire about the Oncology division

Tell us what you are looking for and where you operate. We respond within two working days.

Fields marked * are required.

This form is for business and product information only. To report a side effect or a product complaint, please use the pharmacovigilance form so it reaches the right team.